Oracle announced it agreed to acquire Relsys

On March 23, 2009, Oracle announced it agreed to acquire Relsys, a leading provider of drug safety, risk management and analytics applications for the health sciences industry. Relsys’s best-in-class solutions support adverse event reporting, risk management and drug safety analysis for pharmaceutical, biotechnology, contract research organizations and medical device companies worldwide.

More details on Oracle website:

SAS Does SAAS- Clinical Trials on Cloud

SAS Drug Development—is now available in an online mode. SAS hosts the program, and users log on via the internet. SAS’s goal is to have customers up and running on the system in a month.

SAS® Solutions OnDemand: Drug Development is a hosted solution for aggregating, analyzing and reviewing clinical trials data in order to determine safety and efficacy outcomes. It includes a compliance-enabling platform for efficiently developing, executing and managing the collection, sharing, transformation, analysis and submission of clinical research data.

press release

%d bloggers like this: